106 related articles for article (PubMed ID: 1923590)
1. [Bronchial mucins and infection in cystic fibrosis].
Lamblin G; Ramphal R
Pathol Biol (Paris); 1991 Jun; 39(6):592-7. PubMed ID: 1923590
[No Abstract] [Full Text] [Related]
2. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
[TBL] [Abstract][Full Text] [Related]
3. Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients.
Carfartan G; Gerardin P; Turck D; Husson MO
J Antimicrob Chemother; 2004 Apr; 53(4):686-8. PubMed ID: 14998983
[No Abstract] [Full Text] [Related]
4. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
Hodson ME; Wingfield HJ; Batten JC
Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
[TBL] [Abstract][Full Text] [Related]
5. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
Ramsey DM; Wozniak DJ
Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
[TBL] [Abstract][Full Text] [Related]
6. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
7. The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection.
Davril M; Degroote S; Humbert P; Galabert C; Dumur V; Lafitte JJ; Lamblin G; Roussel P
Glycobiology; 1999 Mar; 9(3):311-21. PubMed ID: 10024669
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomonas aeruginosa infection in cystic fibrosis. The importance of early antibiotic therapy].
Dutau G; Brémont F
Rev Mal Respir; 1990; 7(3):183-5. PubMed ID: 2114027
[No Abstract] [Full Text] [Related]
9. Early infection and progression of cystic fibrosis lung disease.
Koch C
Pediatr Pulmonol; 2002 Sep; 34(3):232-6. PubMed ID: 12203855
[TBL] [Abstract][Full Text] [Related]
10. Update on treatment of pulmonary exacerbations in cystic fibrosis.
Smyth A
Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas in cystic fibrosis sylph or sycophant?
Fick RB
Clin Chest Med; 1981 Jan; 2(1):91-102. PubMed ID: 7030601
[No Abstract] [Full Text] [Related]
12. Detection of Pseudomonas aeruginosa cell-to-cell signals in lung tissue of cystic fibrosis patients.
Favre-Bonté S; Pache JC; Robert J; Blanc D; Pechère JC; van Delden C
Microb Pathog; 2002 Mar; 32(3):143-7. PubMed ID: 11855945
[TBL] [Abstract][Full Text] [Related]
13. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
Kernen Y; Sauty A; Roulet M
Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
[TBL] [Abstract][Full Text] [Related]
14. Differential binding of Pseudomonas aeruginosa to normal and cystic fibrosis tracheobronchial mucins.
Devaraj N; Sheykhnazari M; Warren WS; Bhavanandan VP
Glycobiology; 1994 Jun; 4(3):307-16. PubMed ID: 7949656
[TBL] [Abstract][Full Text] [Related]
15. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
Gill JF; Deretic V; Chakrabarty AM
Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
[TBL] [Abstract][Full Text] [Related]
16. The glycosylation of airway mucins in cystic fibrosis and its relationship with lung infection by Pseudomonas aeruginosa.
Roussel P; Lamblin G
Adv Exp Med Biol; 2003; 535():17-32. PubMed ID: 14714886
[No Abstract] [Full Text] [Related]
17. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
Hubert D; Desmazes-Dufeu N; Dusser D
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
[No Abstract] [Full Text] [Related]
18. Microbial lung infections: new therapeutic strategies.
Döring G
Pathol Biol (Paris); 1991 Jun; 39(6):587-91. PubMed ID: 1923589
[No Abstract] [Full Text] [Related]
19. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
Hata JS; Fick RB
Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
[TBL] [Abstract][Full Text] [Related]
20. Identifying the killer in cystic fibrosis.
Hearst JE; Elliott KE
Nat Med; 1995 Jul; 1(7):626-7. PubMed ID: 7585137
[No Abstract] [Full Text] [Related]
[Next] [New Search]
